Bahl & Gaynor LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings347 positions
Microsoft Corp. | 4.3M | $504.8M | 4.6% | $110.12 | 0.00% | 1 qtr | First report 0 |
Cisco Systems, Inc. | 7.7M | $414.5M | 3.8% | $43.91 | 0.00% | 1 qtr | First report 0 |
NextEra Energy Inc | 2M | $383.6M | 3.5% | $40.08 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co. | 3.5M | $359.2M | 3.3% | $82.70 | 0.00% | 1 qtr | First report 0 |
Home Depot Inc. | 1.7M | $329.4M | 3.0% | $159.31 | 0.00% | 1 qtr | First report 0 |
Texas Instruments Inc. | 2.9M | $311.5M | 2.9% | $86.17 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 2M | $279.9M | 2.6% | $113.77 | 0.00% | 1 qtr | First report 0 |
HONEYWELL INTL INC | 1.7M | $272.1M | 2.5% | $134.76 | 0.00% | 1 qtr | First report 0 |
| 5.7M | $267.4M | 2.5% | $34.00 | — | 1 qtr | First report 0 | |
PEPSICO INC | 2.1M | $261.2M | 2.4% | $96.97 | 0.00% | 1 qtr | First report 0 |
McDonald's Corp. | 1.4M | $257.8M | 2.4% | $159.30 | 0.00% | 1 qtr | First report 0 |
Air Products & Chemicals, Inc. | 1.3M | $250.7M | 2.3% | $159.51 | 0.00% | 1 qtr | First report 0 |
Abbott Laboratories | 3M | $236.1M | 2.2% | $69.76 | 0.00% | 1 qtr | First report 0 |
The Procter & Gamble Co. | 2.2M | $224.1M | 2.1% | $85.93 | 0.00% | 1 qtr | First report 0 |
LOCKHEED MARTIN CORP | 710,413 | $213.2M | 2.0% | $246.00 | 0.00% | 1 qtr | First report 0 |
Chevron Corp. | 1.7M | $209.1M | 1.9% | $90.60 | 0.00% | 1 qtr | First report 0 |
STARBUCKS CORP | 2.7M | $203.8M | 1.9% | $63.07 | 0.00% | 1 qtr | First report 0 |
CROWN CASTLE INTL CORP NEW | 1.6M | $203.3M | 1.9% | $92.36 | 0.00% | 1 qtr | First report 0 |
3M CO | 974,915 | $202.6M | 1.9% | $133.81 | 0.00% | 1 qtr | First report 0 |
PAYCHEX INC | 2.5M | $199M | 1.8% | $63.73 | 0.00% | 1 qtr | First report 0 |
Bahl & Gaynor LLC manages $10.9B across 347 positions as of Q1 2019. Top holdings: MSFT (4.6%), CSCO (3.8%), NEE (3.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3.5/5.0.
First quarter we have for this fund: 347 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $10.9B across 347 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR